Learn on operational challenges to consider, especially related to missing data and protocol deviations.
This session is focusing on the impact of COVID-19 on clinical trials. Joining us to discuss further is Marc Buyse, Founder & Chief Scientific Officer and Everardo Saad, Medical Director of IDDI
